Modified nucleosides derived from tRNA as urinary cancer markers (Homo sapiens)
From WikiPathways
Description
No description
Quality Tags
Ontology Terms
Bibliography
View all... |
- Cho SH, Choi MH, Lee WY, Chung BC; ''Evaluation of urinary nucleosides in breast cancer patients before and after tumor removal.''; Clin Biochem, 2009 PubMed Europe PMC Scholia
- Nakano K, Nakao T, Schram KH, Hammargren WM, McClure TD, Katz M, Petersen E; ''Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.''; Clin Chim Acta, 1993 PubMed Europe PMC Scholia
- Zheng YF, Kong HW, Xiong JH, Lv S, Xu GW; ''Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.''; Clin Biochem, 2005 PubMed Europe PMC Scholia
- Jeng LB, Lo WY, Hsu WY, Lin WD, Lin CT, Lai CC, Tsai FJ; ''Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.''; Rapid Commun Mass Spectrom, 2009 PubMed Europe PMC Scholia
- Rasmuson T, Björk GR; ''Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma.''; Acta Oncol, 1995 PubMed Europe PMC Scholia
- L.A.Agrofoglio, A.Krstulja., C. De Schutter, P.Favetta, R. Delépéee, V.Roy, C.Dejous, H.Hallil, J.-L.Lachaud, N.Lebal, N.Omar Aouled, V.Raimbault, D.Rebiere, S.Dulong, F.Levi, C.Junot, F.Théodoro, A.Pruvost, R.Vidal; ''Detection of urinary modified nucleosides by a bulk acoustic wave MIP sensor - Results and future work''; https://doi.org/10.1016/j.irbm.2014.02.009, 2014 DOI Scholia
- Jeng LB, Lo WY, Hsu WY, Lin WD, Lin CT, Lai CC, Tsai FJ; ''Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.''; Rapid Commun Mass Spectrom, 2009 PubMed Europe PMC Scholia
- Frickenschmidt A, Frohlich H, Bullinger D, Zell A, Laufer S, Gleiter CH, Liebich H, Kammerer B; ''Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients.''; Biomarkers, 2008 PubMed Europe PMC Scholia
- Nakano K, Nakao T, Schram KH, Hammargren WM, McClure TD, Katz M, Petersen E; ''''; , PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
(N)4-acetylcytidine | Metabolite | Breast cancer marker | |
1-methyl- adenosine | Metabolite | Breast cancer marker | |
1-methylguanosine | Metabolite | Breast cancer marker | |
1-methylinosine | Metabolite | Breast cancer marker | |
2-methylguanosine | Metabolite | Breast cancer marker | |
2-pyridone-
5-carboxamide- N1-ribofuranoside | Metabolite | ||
3-methyluridine | Metabolite | Breast cancer marker | |
5'-methylthioadenosine | Metabolite | Breast cancer marker | |
7-methylguanosine | Metabolite | Breast cancer marker | |
8-hydroxy- 2'-deoxyguanosine | Metabolite | ||
Cytidine | Metabolite | ||
N2,N2,7-trimethylguanosine | Metabolite | Breast cancer marker | |
N2-N2-dimethyl- guanosine | Metabolite | Breast cancer marker | |
N6-methyladenosine | Metabolite | Breast cancer marker | |
N6-succinyladenosine | Metabolite | Breast cancer marker | |
N6-threonylcarbomoyladenosine | Metabolite | Breast cancer marker | |
adenosine | Metabolite | Breast cancer marker | |
guanosine | Metabolite | ||
pseudouridine | Metabolite | Breast cancer marker | |
tRNA | Protein | ||
uridine | Metabolite |
Annotated Interactions
No annotated interactions